Table 2.
Characteristics of patients according to first course of treatment in localized and regional stage exocrine pancreatic cancer
| Variable | No. | Surgical FT (n=10,781) | Non-surgical FT (n=5,134) | NT (n=9,283) | p-valuea) |
|---|---|---|---|---|---|
| Age at diagnosis (yr) | |||||
| 0–59 | 13,241 | 3,588 (58.5) | 1,592 (26.0) | 953 (15.5) | < 0.001 |
| 60–69 | 7,108 | 3,707 (52.2) | 1,760 (24.8) | 1,641 (23.1) | |
| 70–79 | 8,272 | 3,084 (37.3) | 1,491 (18.0) | 3,697 (44.7) | |
| ≥ 80 | 3,685 | 402 (10.9) | 291 (7.9) | 2,992 (81.2) | |
| Sex | |||||
| Male | 13,324 | 6,098 (45.8) | 2,869 (21.5) | 4,357 (32.7) | < 0.001 |
| Female | 11,874 | 4,683 (39.4) | 2,265 (19.1) | 4,926 (41.5) | |
| Histology | |||||
| Ductal adenocarcinoma excluding cystic or mucinous (DAC) | 23,481 | 9,296 (39.6) | 5,035 (21.4) | 9,150 (39.0) | < 0.001 |
| Ductal specified as mucinous or cystic adenocarcinoma (ADCm&c) | 1,618 | 1,403 (86.7) | 91 (5.6) | 124 (7.7) | |
| Acinar cell carcinoma (ACC) | 99 | 82 (82.8) | 8 (8.1) | 9 (9.1) | |
Values are presented as number (%). FT, first course of treatment; NT, no active treatment.
a)
Chi-square test across three types of treatment pattern.